# The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

> **NCT07072676** · NA · ENROLLING_BY_INVITATION · sponsor: **LMU Klinikum** · enrollment: 30 (estimated)

## Conditions studied

- Inclusion Body Myositis
- Myotonic Dystrophy 1
- Myotonic Dystrophy 2
- Facio-Scapulo-Humeral Dystrophy
- Limb Girdle Muscular Dystrophies
- Pompe Disease (Infantile-Onset)
- Myasthaenia Gravis
- Lambert Eaton (LEMS)
- Spinal Muscular Atrophy (SMA)
- Guillain Barré Syndrome
- Chronic Inflammatory Demyelinating Polyneuropathy
- Friedreich Ataxia
- Hereditary Motor and Sensory Neuropathies

## Interventions

- **DEVICE:** Assistive gait devices combined with physiotherapy

## Key facts

- **NCT ID:** NCT07072676
- **Lead sponsor:** LMU Klinikum
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-09-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07072676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07072676, "The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07072676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*